HealthEquity (FRA:2HE) Research & Development : €201.4 Mil (TTM As of Jan. 2024)

View and export this data going back to 2014. Start your Free Trial

What is HealthEquity Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. HealthEquity's Research & Development for the three months ended in Jan. 2024 was €50.7 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jan. 2024 was €201.4 Mil.

HealthEquity Research & Development Historical Data

The historical data trend for HealthEquity's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HealthEquity Research & Development Chart

HealthEquity Annual Data

Trend

Jan15

Jan16

Jan17

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

Jan24

Research & Development

Get a 7-Day Free Trial

69.90

102.47

139.11

179.45

200.87

HealthEquity Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Research & Development	Get a 7-Day Free Trial															48.93	48.51	49.51	52.67	50.71

HealthEquity Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €201.4 Mil.

HealthEquity (FRA:2HE) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

HealthEquity Research & Development Related Terms

Thank you for viewing the detailed overview of HealthEquity's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

HealthEquity (FRA:2HE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » HealthEquity Inc (FRA:2HE) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

HQY:USA

Address

15 West Scenic Pointe Drive, Suite 100, Draper, UT, USA, 84020

Website

https://www.healthequity.com

HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. Its technology allows customers to see their tax-advantaged healthcare savings, compare treatment options and pricing, pay healthcare bills, receive benefit information, and earn wellness incentives. The firm primarily partners with health plans and employers and serves as the custodian of its customers' health savings accounts (HSAs). HealthEquity also engages in reimbursement arrangements and offers healthcare incentives to its members. In addition, the company provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.

HealthEquity (FRA:2HE) Headlines

No Headlines